Navigation Links
Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion
Date:9/16/2008

SAN DIEGO, Sept. 16 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that it has secured a new credit facility through City National Bank to provide for additional capital investment in its newly constructed cGMP manufacturing plant. Althea intends to begin offering commercial manufacturing services in the fourth quarter of this year.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)

"We are pleased to report the acquisition of this credit facility with City National Bank which will finance equipment for our recently constructed 30,000 SF cGMP commercial-scale manufacturing building. With truly state-of- the-art equipment, significant production capacities for biotech drugs and filling of finished drug products at the 100,000 unit batch size, this will enable Althea to advance to the next level as a major contract manufacturer. We look forward to working closely with the City National Bank team and are pleased with the attention and emphasis they have invested to this relationship," stated Dr. Magda Marquet, President and Co-CEO of Althea Technologies.

According to Gary Gilmore, Althea's CFO, the credit facility provides for $12 million of working capital and equipment financing for the new facilities.

Stephen Cusato, senior vice president and manager of City National Bank's Commercial Banking Services Office in San Diego, added, "We're excited to offer the bank's resources and our team's expertise to support Althea's expansion into commercial-scale manufacturing. We view this as the first step in a long-term relationship."

About Althea Technologies, Inc.

Althea Technologies, a leading San Diego-based pharmaceutical services firm, provides critical manufacturing services that support researchers worldwide in their advancement of novel therapies and efforts to apply new genomic information. Althea's services include cGMP contract manufacturing of recombinant proteins, DNA-based therapeutics and vaccines, and aseptic filling. For more information, visit http://www.altheatech.com.

About City National Bank

City National Bank is the wholly owned subsidiary of City National Corporation (NYSE: CYN). It is backed by $16.3 billion in total assets, and provides banking, investment and trust services through 62 offices, including 15 full-service regional centers, in Southern California, the San Francisco Bay Area, Nevada and New York City. The company and its eight majority-owned investment affiliates manage or administer $53.5 billion in client investment assets, including $34 billion under direct management.

For more information about City National, visit the company's Website at http://www.cnb.com.

Contact:

Althea Technologies, Inc.

R. Gary Gilmore

Chief Financial Officer

(858) 882-0200

ggilmore@altheatech.com


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. HealthEast Care System Selects Concuitys ClearContracts to Increase Contract Analysis and Negotiation Capabilities and Improve Revenue Cycle Management
2. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
3. Neptune Technologies decided not to re-price options
4. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
5. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
6. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
7. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
8. Anthill Technologies Announces Agreement With Zafgen
9. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
10. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
11. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... ... April 26, 2016 , ... BaseHealth , the comprehensive ... company as Chief Business Officer. Arianpour, a genomics pioneer and visionary commercial leader ... most recently Chief Commercial Officer of Pathway Genomics. He has held senior executive ...
(Date:4/26/2016)... ... April 26, 2016 , ... ... systems, announces the latest technology innovation for its Volume Pattern Generator (VPG) line ... for production of advanced photomasks as well as a solution for mid volume ...
(Date:4/26/2016)... MA (PRWEB) , ... April 26, 2016 , ... This ... Town Scottsdale and will offer attendees an opportunity to get the lowdown on female ... , Over cocktails and appetizers, Dr. Jesse Hade, of Boston IVF - The Arizona ...
(Date:4/26/2016)... ... 26, 2016 , ... Seattle based non-profit, The Institute for ... Corporation. The grant will be used to further the scientific research goals of ... http://www.ivsci.org , In accounting the grant to the IVS, Mr. Glenn ...
Breaking Biology Technology:
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
(Date:3/18/2016)... March 18, 2016 --> ... Biometrics, ICT, Manned & Unmanned Vehicles, Physical infrastructure and Perimeter ... companies in the border security market and the continuing migration ... Europe has led visiongain to publish ... success. --> defence & security companies in ...
Breaking Biology News(10 mins):